I felt an excitement at the U.S. Conference on AIDS (USCA) that I hadn’t felt for a while. We’re at the start of something new, something important, that’s just starting to catch fire. I can’t tell you how many conversations I had with government, national, and community leaders last week at USCA about what treatment as prevention and PrEP mean for our work and our lives. The implications of the most recent data released at the International AIDS Conference regarding treatment as prevention and PrEP are starting to take hold. Follow up of HPTN 052 found no cases of HIV transmission from someone who was virally suppressed, adding to the evidence from other studies. Studies on PrEP reinforced that it is more than 90% effective when taken as prescribed. People who have near-perfect adherence to PrEP have even better results.